The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Catheter-Based Renal Denervation System Market Research Report 2024
Synopsis
Renal Denervation (RDN) is a percutaneous interventional treatment method. It mainly uses energy such as radio frequency and ultrasound to eliminate the afferent and efferent nerves in the renal artery, blocking the signal conduction between the brain and sympathetic nerves to a certain extent, thereby reducing the risk of high blood pressure. The sympathetic nerve excitability of patients with high blood pressure can achieve long-term and stable blood pressure lowering effects with one minimally invasive surgery.
Currently, the typical models of Renal Denervation (RDN) System include Recor Medical’s Paradise and Medtronic’s Simplicity Spyral, etc.
The global Catheter-Based Renal Denervation System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Catheter-Based Renal Denervation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Catheter-Based Renal Denervation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Catheter-Based Renal Denervation System include Medtronic, Recor Medical, Boston Scientific, Cardiosonic, Shanghai Bioheart, Shanghai Golden Leaf, Suzhou SyMap, MicroPort and Cryofocus Medtech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Catheter-Based Renal Denervation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Catheter-Based Renal Denervation System.
Report Scope
The Catheter-Based Renal Denervation System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Catheter-Based Renal Denervation System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Catheter-Based Renal Denervation System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Recor Medical
Boston Scientific
Cardiosonic
Shanghai Bioheart
Shanghai Golden Leaf
Suzhou SyMap
MicroPort
Cryofocus Medtech
Shanghai Hantong
Segment by Type
Radiofrequency Ablation
Ultrasound Ablation
Others
Segment by Application
High Blood Pressure Treatment
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Catheter-Based Renal Denervation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Catheter-Based Renal Denervation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Renal Denervation (RDN) is a percutaneous interventional treatment method. It mainly uses energy such as radio frequency and ultrasound to eliminate the afferent and efferent nerves in the renal artery, blocking the signal conduction between the brain and sympathetic nerves to a certain extent, thereby reducing the risk of high blood pressure. The sympathetic nerve excitability of patients with high blood pressure can achieve long-term and stable blood pressure lowering effects with one minimally invasive surgery.
Currently, the typical models of Renal Denervation (RDN) System include Recor Medical’s Paradise and Medtronic’s Simplicity Spyral, etc.
The global Catheter-Based Renal Denervation System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Catheter-Based Renal Denervation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Catheter-Based Renal Denervation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Catheter-Based Renal Denervation System include Medtronic, Recor Medical, Boston Scientific, Cardiosonic, Shanghai Bioheart, Shanghai Golden Leaf, Suzhou SyMap, MicroPort and Cryofocus Medtech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Catheter-Based Renal Denervation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Catheter-Based Renal Denervation System.
Report Scope
The Catheter-Based Renal Denervation System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Catheter-Based Renal Denervation System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Catheter-Based Renal Denervation System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Recor Medical
Boston Scientific
Cardiosonic
Shanghai Bioheart
Shanghai Golden Leaf
Suzhou SyMap
MicroPort
Cryofocus Medtech
Shanghai Hantong
Segment by Type
Radiofrequency Ablation
Ultrasound Ablation
Others
Segment by Application
High Blood Pressure Treatment
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Catheter-Based Renal Denervation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Catheter-Based Renal Denervation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Catheter-Based Renal Denervation System Market Overview
1.1 Product Overview and Scope of Catheter-Based Renal Denervation System
1.2 Catheter-Based Renal Denervation System Segment by Type
1.2.1 Global Catheter-Based Renal Denervation System Market Value Comparison by Type (2024-2030)
1.2.2 Radiofrequency Ablation
1.2.3 Ultrasound Ablation
1.2.4 Others
1.3 Catheter-Based Renal Denervation System Segment by Application
1.3.1 Global Catheter-Based Renal Denervation System Market Value by Application: (2024-2030)
1.3.2 High Blood Pressure Treatment
1.3.3 Others
1.4 Global Catheter-Based Renal Denervation System Market Size Estimates and Forecasts
1.4.1 Global Catheter-Based Renal Denervation System Revenue 2019-2030
1.4.2 Global Catheter-Based Renal Denervation System Sales 2019-2030
1.4.3 Global Catheter-Based Renal Denervation System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Catheter-Based Renal Denervation System Market Competition by Manufacturers
2.1 Global Catheter-Based Renal Denervation System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Catheter-Based Renal Denervation System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Catheter-Based Renal Denervation System Average Price by Manufacturers (2019-2024)
2.4 Global Catheter-Based Renal Denervation System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Catheter-Based Renal Denervation System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Catheter-Based Renal Denervation System, Product Type & Application
2.7 Catheter-Based Renal Denervation System Market Competitive Situation and Trends
2.7.1 Catheter-Based Renal Denervation System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Catheter-Based Renal Denervation System Players Market Share by Revenue
2.7.3 Global Catheter-Based Renal Denervation System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Catheter-Based Renal Denervation System Retrospective Market Scenario by Region
3.1 Global Catheter-Based Renal Denervation System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Catheter-Based Renal Denervation System Global Catheter-Based Renal Denervation System Sales by Region: 2019-2030
3.2.1 Global Catheter-Based Renal Denervation System Sales by Region: 2019-2024
3.2.2 Global Catheter-Based Renal Denervation System Sales by Region: 2025-2030
3.3 Global Catheter-Based Renal Denervation System Global Catheter-Based Renal Denervation System Revenue by Region: 2019-2030
3.3.1 Global Catheter-Based Renal Denervation System Revenue by Region: 2019-2024
3.3.2 Global Catheter-Based Renal Denervation System Revenue by Region: 2025-2030
3.4 North America Catheter-Based Renal Denervation System Market Facts & Figures by Country
3.4.1 North America Catheter-Based Renal Denervation System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Catheter-Based Renal Denervation System Sales by Country (2019-2030)
3.4.3 North America Catheter-Based Renal Denervation System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Catheter-Based Renal Denervation System Market Facts & Figures by Country
3.5.1 Europe Catheter-Based Renal Denervation System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Catheter-Based Renal Denervation System Sales by Country (2019-2030)
3.5.3 Europe Catheter-Based Renal Denervation System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Catheter-Based Renal Denervation System Market Facts & Figures by Country
3.6.1 Asia Pacific Catheter-Based Renal Denervation System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Catheter-Based Renal Denervation System Sales by Country (2019-2030)
3.6.3 Asia Pacific Catheter-Based Renal Denervation System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Catheter-Based Renal Denervation System Market Facts & Figures by Country
3.7.1 Latin America Catheter-Based Renal Denervation System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Catheter-Based Renal Denervation System Sales by Country (2019-2030)
3.7.3 Latin America Catheter-Based Renal Denervation System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Catheter-Based Renal Denervation System Market Facts & Figures by Country
3.8.1 Middle East and Africa Catheter-Based Renal Denervation System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Catheter-Based Renal Denervation System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Catheter-Based Renal Denervation System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Catheter-Based Renal Denervation System Sales by Type (2019-2030)
4.1.1 Global Catheter-Based Renal Denervation System Sales by Type (2019-2024)
4.1.2 Global Catheter-Based Renal Denervation System Sales by Type (2025-2030)
4.1.3 Global Catheter-Based Renal Denervation System Sales Market Share by Type (2019-2030)
4.2 Global Catheter-Based Renal Denervation System Revenue by Type (2019-2030)
4.2.1 Global Catheter-Based Renal Denervation System Revenue by Type (2019-2024)
4.2.2 Global Catheter-Based Renal Denervation System Revenue by Type (2025-2030)
4.2.3 Global Catheter-Based Renal Denervation System Revenue Market Share by Type (2019-2030)
4.3 Global Catheter-Based Renal Denervation System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Catheter-Based Renal Denervation System Sales by Application (2019-2030)
5.1.1 Global Catheter-Based Renal Denervation System Sales by Application (2019-2024)
5.1.2 Global Catheter-Based Renal Denervation System Sales by Application (2025-2030)
5.1.3 Global Catheter-Based Renal Denervation System Sales Market Share by Application (2019-2030)
5.2 Global Catheter-Based Renal Denervation System Revenue by Application (2019-2030)
5.2.1 Global Catheter-Based Renal Denervation System Revenue by Application (2019-2024)
5.2.2 Global Catheter-Based Renal Denervation System Revenue by Application (2025-2030)
5.2.3 Global Catheter-Based Renal Denervation System Revenue Market Share by Application (2019-2030)
5.3 Global Catheter-Based Renal Denervation System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Catheter-Based Renal Denervation System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Catheter-Based Renal Denervation System Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Recor Medical
6.2.1 Recor Medical Corporation Information
6.2.2 Recor Medical Description and Business Overview
6.2.3 Recor Medical Catheter-Based Renal Denervation System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Recor Medical Catheter-Based Renal Denervation System Product Portfolio
6.2.5 Recor Medical Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Catheter-Based Renal Denervation System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boston Scientific Catheter-Based Renal Denervation System Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Cardiosonic
6.4.1 Cardiosonic Corporation Information
6.4.2 Cardiosonic Description and Business Overview
6.4.3 Cardiosonic Catheter-Based Renal Denervation System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cardiosonic Catheter-Based Renal Denervation System Product Portfolio
6.4.5 Cardiosonic Recent Developments/Updates
6.5 Shanghai Bioheart
6.5.1 Shanghai Bioheart Corporation Information
6.5.2 Shanghai Bioheart Description and Business Overview
6.5.3 Shanghai Bioheart Catheter-Based Renal Denervation System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Bioheart Catheter-Based Renal Denervation System Product Portfolio
6.5.5 Shanghai Bioheart Recent Developments/Updates
6.6 Shanghai Golden Leaf
6.6.1 Shanghai Golden Leaf Corporation Information
6.6.2 Shanghai Golden Leaf Description and Business Overview
6.6.3 Shanghai Golden Leaf Catheter-Based Renal Denervation System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanghai Golden Leaf Catheter-Based Renal Denervation System Product Portfolio
6.6.5 Shanghai Golden Leaf Recent Developments/Updates
6.7 Suzhou SyMap
6.6.1 Suzhou SyMap Corporation Information
6.6.2 Suzhou SyMap Description and Business Overview
6.6.3 Suzhou SyMap Catheter-Based Renal Denervation System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Suzhou SyMap Catheter-Based Renal Denervation System Product Portfolio
6.7.5 Suzhou SyMap Recent Developments/Updates
6.8 MicroPort
6.8.1 MicroPort Corporation Information
6.8.2 MicroPort Description and Business Overview
6.8.3 MicroPort Catheter-Based Renal Denervation System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MicroPort Catheter-Based Renal Denervation System Product Portfolio
6.8.5 MicroPort Recent Developments/Updates
6.9 Cryofocus Medtech
6.9.1 Cryofocus Medtech Corporation Information
6.9.2 Cryofocus Medtech Description and Business Overview
6.9.3 Cryofocus Medtech Catheter-Based Renal Denervation System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cryofocus Medtech Catheter-Based Renal Denervation System Product Portfolio
6.9.5 Cryofocus Medtech Recent Developments/Updates
6.10 Shanghai Hantong
6.10.1 Shanghai Hantong Corporation Information
6.10.2 Shanghai Hantong Description and Business Overview
6.10.3 Shanghai Hantong Catheter-Based Renal Denervation System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Hantong Catheter-Based Renal Denervation System Product Portfolio
6.10.5 Shanghai Hantong Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Catheter-Based Renal Denervation System Industry Chain Analysis
7.2 Catheter-Based Renal Denervation System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Catheter-Based Renal Denervation System Production Mode & Process
7.4 Catheter-Based Renal Denervation System Sales and Marketing
7.4.1 Catheter-Based Renal Denervation System Sales Channels
7.4.2 Catheter-Based Renal Denervation System Distributors
7.5 Catheter-Based Renal Denervation System Customers
8 Catheter-Based Renal Denervation System Market Dynamics
8.1 Catheter-Based Renal Denervation System Industry Trends
8.2 Catheter-Based Renal Denervation System Market Drivers
8.3 Catheter-Based Renal Denervation System Market Challenges
8.4 Catheter-Based Renal Denervation System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
